---
title: "LIVZON PHARMA's application for marketing authorization of Lecanemab injection has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270913593.md"
description: "LIVZON PHARMA announced that its holding subsidiary, LIVZON Monoclonal Antibody, received a notification from the National Medical Products Administration. The application for the domestic production drug registration and marketing authorization of the monoclonal antibody injection, jointly developed with Beijing Xinkanghe, has been accepted. The intended indication is for adult patients with moderate to severe plaque psoriasis suitable for systemic therapy or phototherapy"
datetime: "2025-12-28T09:56:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270913593.md)
  - [en](https://longbridge.com/en/news/270913593.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270913593.md)
generator: "portal-rs"
---

# LIVZON PHARMA's application for marketing authorization of Lecanemab injection has been accepted

LIVZON PHARMA (01513.HK) announced that its holding subsidiary, LIVZON Monoclonal Antibody, received a notification from the National Medical Products Administration. The application for the domestic production drug registration and marketing authorization of Lakanqita Monoclonal Antibody Injection, jointly developed with Beijing Xinkanghe, has been accepted. The intended indication is for adult patients with moderate to severe plaque psoriasis suitable for systemic therapy or phototherapy

### Related Stocks

- [000513.CN](https://longbridge.com/en/quote/000513.CN.md)
- [01513.HK](https://longbridge.com/en/quote/01513.HK.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Livzon Pharma FY26 H1 net profit drops 27.23% to RMB 932.2 million; revenue falls 20.28% to RMB 5 billion](https://longbridge.com/en/news/296600877.md)
- [Labubu maker Pop Mart set for drastic growth slowdown as bears gather](https://longbridge.com/en/news/296428956.md)
- [POP MART's Twinkle Twinkle Farm Tales Series Sells Out Instantly at Launch; Hidden Edition Resold at ~14x Premium](https://longbridge.com/en/news/296560057.md)
- [SMOORE INTL  1H26 Net Profit Up 16.2% YoY to RMB572M; Interim DPS Maintained at HKD0.2](https://longbridge.com/en/news/296421803.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**